beta-lactams has been researched along with cyslabdan in 2 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (cyslabdan) | Trials (cyslabdan) | Recent Studies (post-2010) (cyslabdan) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 9 | 0 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumoto, A; Hanaki, H; Kim, YP; Omura, S; Shiomi, K; Tomoda, H | 1 |
| Inokoshi, J; Koyama, N; Tomoda, H | 1 |
1 review(s) available for beta-lactams and cyslabdan
| Article | Year |
|---|---|
Anti-infectious agents against MRSA.
Topics: Acetylcysteine; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cell Wall; Diterpenes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycotoxins; Organothiophosphorus Compounds; Peptidoglycan; Spiro Compounds; Teichoic Acids; Vancomycin; Virulence Factors; Xanthophylls | 2012 |
1 other study(ies) available for beta-lactams and cyslabdan
| Article | Year |
|---|---|
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
Topics: Acetylcysteine; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Diterpenes; Drug Synergism; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptomyces | 2008 |